NHSN-01-01 | NHSN overview and purpose | 0 |
NHSN-01-02 | NHSN components and modules | 0 |
NHSN-01-03 | Patient Safety Component modules | 0 |
NHSN-01-04 | Long-term Care Facility Component scope | 0 |
NHSN-01-05 | Refer outpatient hemodialysis to Dialysis Component | 0 |
NHSN-01-06 | Healthcare Personnel Safety Component modules | 0 |
NHSN-01-07 | Restrict HPS Exposure Module to existing reporters | 0 |
NHSN-01-08 | Healthcare Personnel Vaccination Module | 0 |
NHSN-01-09 | Biovigilance Hemovigilance Module | 0 |
NHSN-01-10 | Outpatient Procedure Component modules | 0 |
NHSN-01-11 | Neonatal Component scope | 0 |
NHSN-01-12 | Follow full NHSN protocol for in-plan events | 0 |
NHSN-01-13 | Active surveillance by trained infection preventionists | 0 |
NHSN-01-14 | Active SSI surveillance with NHSN criteria | 0 |
NHSN-01-15 | Device denominator collection and validation | 0 |
NHSN-01-16 | AUR data submitted electronically | 0 |
NHSN-01-17 | MDRO/CDI module options | 0 |
NHSN-02-01 | Scope exclusions for other event types | 0 |
NHSN-02-02 | Excluded community-associated organisms | 0 |
NHSN-02-03 | Organ donation cases and denominator counts | 0 |
NHSN-02-04 | Hospice and comfort care are not exclusions | 0 |
NHSN-02-05 | Eligibility of post-mortem specimens | 0 |
NHSN-02-06 | Newborn infection timing and exclusions | 0 |
NHSN-02-07 | Latent infection reactivation excluded | 0 |
NHSN-02-08 | Observation patients in inpatient locations | 0 |
NHSN-02-09 | Infection window period definition | 0 |
NHSN-02-10 | Window start when no diagnostic test | 0 |
NHSN-02-11 | Earliest date when multiple criteria are met | 0 |
NHSN-02-12 | Extended endocarditis infection window | 0 |
NHSN-02-13 | Date of event and POA or HAI status | 0 |
NHSN-02-14 | Acceptable documentation and physician diagnosis | 0 |
NHSN-02-15 | Location of attribution assignment | 0 |
NHSN-02-16 | Transfer rule for attribution | 0 |
NHSN-02-17 | Repeat infection timeframe rules | 0 |
NHSN-02-18 | Secondary BSI attribution period | 0 |
NHSN-02-19 | Criteria for a secondary BSI | 0 |
NHSN-02-20 | Endocarditis secondary BSI period | 0 |
NHSN-02-21 | Secondary BSI attribution period composition | 0 |
NHSN-02-22 | Assigning pathogens to secondary BSI events | 0 |
NHSN-02-23 | MBI-LCBI designation held during BSI RIT | 0 |
NHSN-02-24 | Organisms excluded from a site definition | 0 |
NHSN-02-25 | Verify primary status before applying a BSI RIT | 0 |
NHSN-03-01 | Monthly reporting plan entry | 0 |
NHSN-03-02 | In-plan surveillance follows the full protocol | 0 |
NHSN-03-03 | Annual facility survey completion | 0 |
NHSN-03-04 | Survey deadline and reporting plan lock | 0 |
NHSN-03-05 | Survey form matched to facility type | 0 |
NHSN-04-01 | Chapter burden and prevention context | 0 |
NHSN-04-02 | Inpatient surveillance setting scope | 0 |
NHSN-04-03 | Post-discharge CLABSI attribution and communication | 0 |
NHSN-04-04 | Universal NHSN terms adopted | 0 |
NHSN-04-05 | Bloodstream infection definition scope | 0 |
NHSN-04-06 | Primary bloodstream infection definition | 0 |
NHSN-04-07 | Secondary bloodstream infection definition | 0 |
NHSN-04-08 | Secondary BSI attribution period | 0 |
NHSN-04-09 | Infusion meaning for surveillance | 0 |
NHSN-04-10 | Access definition for central lines | 0 |
NHSN-04-100 | Standardized utilization ratio calculation | 0 |
NHSN-04-101 | CLABSI rate per 1000 central line days | 0 |
NHSN-04-102 | Central line utilization ratio | 0 |
NHSN-04-103 | CLABSI measures available in NHSN | 0 |
NHSN-04-104 | CLABSI SIR measure | 0 |
NHSN-04-105 | MBI-LCBI SIR measure | 0 |
NHSN-04-106 | Location CLABSI rate | 0 |
NHSN-04-107 | Location MBI-LCBI rate | 0 |
NHSN-04-108 | Central line standardized utilization ratio | 0 |
NHSN-04-109 | Device utilization ratio measure | 0 |
NHSN-04-11 | First access and port de-access | 0 |
NHSN-04-110 | Exclusions from MBI-LCBI measures | 0 |
NHSN-04-111 | MBI-LCBI excluded from CLABSI measures | 0 |
NHSN-04-112 | ECMO cases excluded from CLABSI measures | 0 |
NHSN-04-113 | VAD cases excluded from CLABSI measures | 0 |
NHSN-04-114 | MSBP cases excluded from CLABSI measures | 0 |
NHSN-04-115 | EB cases excluded from CLABSI measures | 0 |
NHSN-04-116 | Patient self-injection excluded from CLABSI measures | 0 |
NHSN-04-117 | Pus at vascular site excluded | 0 |
NHSN-04-118 | Purpose of secondary BSI attribution | 0 |
NHSN-04-119 | Requirements for secondary BSI attribution | 0 |
NHSN-04-12 | Dialysis patients and attribution | 0 |
NHSN-04-120 | Matching organism within attribution period | 0 |
NHSN-04-121 | Blood organism used as criterion element | 0 |
NHSN-04-122 | Secondary BSI attribution to NEC | 0 |
NHSN-04-123 | Necrotizing enterocolitis age and criteria | 0 |
NHSN-04-124 | NEC 1 clinical and imaging criterion | 0 |
NHSN-04-125 | NEC 2 surgical criterion | 0 |
NHSN-04-126 | NEC imaging and age limits | 0 |
NHSN-04-127 | Endocarditis attribution exception | 0 |
NHSN-04-128 | Secondary BSI attribution method setup | 0 |
NHSN-04-129 | Eligible site criteria for Scenario 1 | 0 |
NHSN-04-13 | Central line definition | 0 |
NHSN-04-130 | Eligible site criteria for Scenario 2 | 0 |
NHSN-04-131 | Unmatched blood organism reporting | 0 |
NHSN-04-132 | PVAP secondary BSI reporting route | 0 |
NHSN-04-133 | Sources that cannot carry secondary BSI | 0 |
NHSN-04-134 | Lower respiratory secondary BSI routes | 0 |
NHSN-04-135 | Site organism exclusions carry over | 0 |
NHSN-04-136 | Genus and species matching | 0 |
NHSN-04-137 | Genus level matching | 0 |
NHSN-04-138 | Staphylococcus and Streptococcus exception | 0 |
NHSN-04-139 | Yeast matching exception | 0 |
NHSN-04-14 | Central line determination notes | 0 |
NHSN-04-140 | Antibiogram matching not required | 0 |
NHSN-04-141 | Blood specimen must meet BSI criteria | 0 |
NHSN-04-142 | Adding secondary BSI pathogens | 0 |
NHSN-04-143 | MBI-LCBI designation during its RIT | 0 |
NHSN-04-144 | Matching pathogen determines secondary status | 0 |
NHSN-04-145 | One secondary BSI assigned to two sites | 0 |
NHSN-04-146 | Excluded pathogens remain excluded | 0 |
NHSN-04-147 | One reported event per RIT | 0 |
NHSN-04-148 | Secondary BSI attributed to NEC | 0 |
NHSN-04-149 | PVAP secondary BSI match and timing | 0 |
NHSN-04-15 | Central line types | 0 |
NHSN-04-150 | No secondary BSI after histopathology-only PVAP | 0 |
NHSN-04-151 | No secondary BSI without a respiratory match | 0 |
NHSN-04-152 | Organisms barred from PVAP secondary status | 0 |
NHSN-04-16 | Eligible central line threshold | 0 |
NHSN-04-17 | Eligible BSI organism rule | 0 |
NHSN-04-18 | CLABSI event definition | 0 |
NHSN-04-19 | Central line day counting | 0 |
NHSN-04-20 | Denominator device day counting | 0 |
NHSN-04-21 | Devices excluded from central line status | 0 |
NHSN-04-22 | LCBI criteria application | 0 |
NHSN-04-23 | LCBI 1 recognized pathogen criterion | 0 |
NHSN-04-24 | LCBI 1 hierarchy and date of event | 0 |
NHSN-04-25 | LCBI 2 symptom and commensal criterion | 0 |
NHSN-04-26 | LCBI 2 window and date of event | 0 |
NHSN-04-27 | LCBI 3 infant symptom and commensal criterion | 0 |
NHSN-04-28 | LCBI 3 window and date of event | 0 |
NHSN-04-29 | MBI-LCBI prerequisite and date of event | 0 |
NHSN-04-30 | MBI-LCBI 1 organism and host criteria | 0 |
NHSN-04-31 | MBI-LCBI 2 organism and host criteria | 0 |
NHSN-04-32 | MBI-LCBI 3 organism and host criteria | 0 |
NHSN-04-33 | MBI-LCBI hierarchy and ANC combination | 0 |
NHSN-04-34 | ANC calculation for neutropenia | 0 |
NHSN-04-35 | CLABSI exclusion reporting rules | 0 |
NHSN-04-36 | ECMO exclusion reporting | 0 |
NHSN-04-37 | VAD exclusion reporting | 0 |
NHSN-04-38 | Patient injection exclusion | 0 |
NHSN-04-39 | Epidermolysis bullosa exclusion | 0 |
NHSN-04-40 | MSBP exclusion reporting | 0 |
NHSN-04-41 | Pus at vascular access site exclusion | 0 |
NHSN-04-42 | Group B Streptococcus reporting | 0 |
NHSN-04-43 | LCBI inside BSI RIT | 0 |
NHSN-04-44 | MBI-LCBI inside BSI RIT | 0 |
NHSN-04-45 | Primary BSI starts 14-day RIT | 0 |
NHSN-04-46 | Secondary BSI does not start BSI RIT | 0 |
NHSN-04-47 | Present on admission blood specimens | 0 |
NHSN-04-48 | Two or more blood specimens | 0 |
NHSN-04-49 | In-plan specimen inclusion | 0 |
NHSN-04-50 | Catheter tip culture prohibition | 0 |
NHSN-04-51 | No other organisms meaning | 0 |
NHSN-04-52 | Non-MBI organism during MBI RIT | 0 |
NHSN-04-53 | Device association and multiple lines | 0 |
NHSN-04-54 | Removal and discharge association | 0 |
NHSN-04-55 | BSI on removal or discharge day | 0 |
NHSN-04-56 | Eligibility continues without a device-free day | 0 |
NHSN-04-57 | Device day count restarts after a device-free day | 0 |
NHSN-04-58 | Placement starts device day counting | 0 |
NHSN-04-59 | Eligible central line threshold | 0 |
NHSN-04-60 | Recognized pathogen definition | 0 |
NHSN-04-61 | Viruses and parasites excluded from LCBI | 0 |
NHSN-04-62 | Enteric organisms excluded from primary LCBI | 0 |
NHSN-04-63 | Fungi barred from all NHSN definitions | 0 |
NHSN-04-64 | Pathogen order in mixed LCBI 1 events | 0 |
NHSN-04-65 | Matching speciated and unspeciated blood organisms | 0 |
NHSN-04-66 | Single common commensal treated as contaminant | 0 |
NHSN-04-67 | Reporting matched genus and species results | 0 |
NHSN-04-68 | Fallback reporting when identification is incomplete | 0 |
NHSN-04-69 | Neutropenia definition for MBI-LCBI | 0 |
NHSN-04-70 | Choosing qualifying neutropenia days | 0 |
NHSN-04-71 | MBI-LCBI 1 with neutropenia | 0 |
NHSN-04-72 | MBI-LCBI 2 with neutropenia | 0 |
NHSN-04-73 | Monthly summary reporting | 0 |
NHSN-04-74 | Primary BSI numerator reporting | 0 |
NHSN-04-75 | Data collected on the Primary BSI form | 0 |
NHSN-04-76 | Report no events during a zero month | 0 |
NHSN-04-77 | Denominator device day count examples | 0 |
NHSN-04-78 | Device day counted when line present | 0 |
NHSN-04-79 | Day 1 starts on inpatient insertion | 0 |
NHSN-04-80 | Day 1 starts on inpatient admission with a line | 0 |
NHSN-04-81 | Counting stops when the line is removed | 0 |
NHSN-04-82 | Port access does not change device day count | 0 |
NHSN-04-83 | Denominator data collection methods | 0 |
NHSN-04-84 | Daily denominator collection | 0 |
NHSN-04-85 | One central line per patient per day | 0 |
NHSN-04-86 | All central lines counted regardless of access | 0 |
NHSN-04-87 | Separate permanent and temporary line counts | 0 |
NHSN-04-88 | Temporary line takes precedence | 0 |
NHSN-04-89 | NICU denominator counts by birth weight | 0 |
NHSN-04-90 | Weekly sampling of denominator data | 0 |
NHSN-04-91 | Weekend days excluded from sampling | 0 |
NHSN-04-92 | Data entered for sampled denominators | 0 |
NHSN-04-93 | Minimum central line days for sampling | 0 |
NHSN-04-94 | Validation of electronic denominator data | 0 |
NHSN-04-95 | Revalidation after a system change | 0 |
NHSN-04-96 | CLABSI data analysis | 0 |
NHSN-04-97 | Standardized infection ratio calculation | 0 |
NHSN-04-98 | SIR across locations | 0 |
NHSN-04-99 | Minimum predicted events for SIR | 0 |
NHSN-05-01 | Voluntary central line insertion practice monitoring | 0 |
NHSN-05-02 | CLIP event capture on CDC 57.125 | 0 |
NHSN-05-03 | CLIP adherence rate calculation | 0 |
NHSN-05-04 | NHSN CLIP bundle compliance criteria | 0 |
NHSN-06-01 | PedVAP surveillance scope and discharge attribution | 0 |
NHSN-06-02 | Surveillance definition of a ventilator | 0 |
NHSN-06-03 | VAP timing and ventilator association | 0 |
NHSN-06-04 | Eligible imaging evidence and persistence | 0 |
NHSN-06-05 | PNEU classification and reporting rules | 0 |
NHSN-06-06 | Organisms excluded from PNEU criteria | 0 |
NHSN-06-07 | Secondary BSI attribution with excluded pathogens | 0 |
NHSN-06-08 | Clinically defined pneumonia PNU1 | 0 |
NHSN-06-09 | PNU1 criteria for infants and children | 0 |
NHSN-06-10 | Pneumonia with laboratory findings PNU2 | 0 |
NHSN-06-11 | Pneumonia in immunocompromised patients PNU3 | 0 |
NHSN-06-12 | Purulent respiratory secretions definition | 0 |
NHSN-06-13 | Laboratory specimen criteria for PNEU | 0 |
NHSN-06-14 | PNEU numerator reporting and no-event box | 0 |
NHSN-06-15 | Ventilator day and patient day collection | 0 |
NHSN-06-16 | VAP rate and device utilization ratio | 0 |
NHSN-07-01 | Scope and burden of urinary tract infection surveillance | 0 |
NHSN-07-02 | Locations eligible for CAUTI surveillance | 0 |
NHSN-07-03 | Terms governing urinary tract infection classification | 0 |
NHSN-07-04 | Which devices count as indwelling urinary catheters | 0 |
NHSN-07-05 | Two-day catheter association rule | 0 |
NHSN-07-06 | Coding basis for neurogenic bladder status | 0 |
NHSN-07-07 | Catheter-associated symptomatic UTI criterion | 0 |
NHSN-07-08 | Non-catheter-associated symptomatic UTI criterion | 0 |
NHSN-07-09 | Symptomatic UTI criterion for infants | 0 |
NHSN-07-10 | Asymptomatic bacteremic UTI criterion | 0 |
NHSN-07-11 | Organisms that can meet UTI criteria | 0 |
NHSN-07-12 | Acceptable documentation of localising symptoms | 0 |
NHSN-07-13 | Capturing each CAUTI on the UTI form | 0 |
NHSN-07-14 | Reporting months with no CAUTI events | 0 |
NHSN-07-15 | Daily manual denominator collection | 0 |
NHSN-07-16 | Weekly sampling of denominator data | 0 |
NHSN-07-17 | Validating electronic denominator counts | 0 |
NHSN-07-18 | Using the standardized infection ratio | 0 |
NHSN-07-19 | Using the standardized utilization ratio | 0 |
NHSN-07-20 | CAUTI rate and device utilization ratio | 0 |
NHSN-09-01 | Purpose and burden of SSI surveillance | 0 |
NHSN-09-02 | Care settings covered by SSI surveillance | 0 |
NHSN-09-03 | Plan, collect and report SSI data | 0 |
NHSN-09-04 | Active prospective case finding | 0 |
NHSN-09-05 | Code mapping and NHSN procedure definition | 0 |
NHSN-09-06 | Thirty and ninety day surveillance periods | 0 |
NHSN-09-07 | Date of event and element timing | 0 |
NHSN-09-08 | Secondary bloodstream infection attribution | 0 |
NHSN-09-09 | ASA score eligibility | 0 |
NHSN-09-10 | Diabetes field definition | 0 |
NHSN-09-11 | Wound class assignment and clean restriction | 0 |
NHSN-09-12 | Remaining denominator data fields | 0 |
NHSN-09-13 | Superficial incisional SSI criterion | 0 |
NHSN-09-14 | Deep incisional SSI criterion | 0 |
NHSN-09-15 | Organ/space SSI criterion | 0 |
NHSN-09-16 | SSI event form completion | 0 |
NHSN-09-17 | Excluded organisms | 0 |
NHSN-09-18 | Infection present at time of surgery | 0 |
NHSN-09-19 | Deepest tissue level reporting | 0 |
NHSN-09-20 | Attribution across procedures and incisions | 0 |
NHSN-09-21 | Secondary incision sites | 0 |
NHSN-09-22 | SSI detected at another facility | 0 |
NHSN-09-23 | SSI after invasive manipulation or access | 0 |
NHSN-09-24 | Reporting despite post-operative circumstances | 0 |
NHSN-09-25 | Denominator form for each monitored category | 0 |
NHSN-09-26 | Multiple monitored categories in one operating room trip | 0 |
NHSN-09-27 | Combined duration for procedures through one incision | 0 |
NHSN-09-28 | Durations for procedures through separate incisions | 0 |
NHSN-09-29 | One form for one category with several codes | 0 |
NHSN-09-30 | Revision hip and knee prior infection flag | 0 |
NHSN-09-31 | Separate forms for the same category | 0 |
NHSN-09-32 | Colon and hernia procedure counting | 0 |
NHSN-09-33 | Procedures through the same incision within 24 hours | 0 |
NHSN-09-34 | Patient death in the operating room | 0 |
NHSN-09-35 | Abdominal and vaginal hysterectomy classification | 0 |
NHSN-09-36 | SSI rate per 100 operative procedures | 0 |
NHSN-09-37 | Standardized infection ratio calculation | 0 |
NHSN-09-38 | Baseline differences in SSI SIR reporting | 0 |
NHSN-09-39 | Choosing the applicable SSI SIR model | 0 |
NHSN-09-40 | Universal exclusions before SIR calculation | 0 |
NHSN-09-41 | Event types allowed for each procedure category | 0 |
NHSN-09-42 | Maximum procedures per patient per day | 0 |
NHSN-10-01 | Purpose and tiers of VAE surveillance | 0 |
NHSN-10-02 | Terms and measurement conventions | 0 |
NHSN-10-03 | Eligible adult inpatient locations | 0 |
NHSN-10-04 | Patients included and excluded | 0 |
NHSN-10-05 | Minimum ventilation and event tiers | 0 |
NHSN-10-06 | Daily minimum PEEP and FiO2 measurement | 0 |
NHSN-10-07 | Event date and VAE window | 0 |
NHSN-10-08 | Fourteen-day event period | 0 |
NHSN-10-09 | VAC oxygenation criteria | 0 |
NHSN-10-10 | IVAC infection and antimicrobial criteria | 0 |
NHSN-10-11 | PVAP positive culture thresholds | 0 |
NHSN-10-12 | PVAP purulent secretions with organism | 0 |
NHSN-10-13 | PVAP alternate positive tests | 0 |
NHSN-10-14 | Location of attribution and transfer rule | 0 |
NHSN-10-15 | In-plan surveillance and definition hierarchy | 0 |
NHSN-10-16 | Organ donation and VAC or IVAC limits | 0 |
NHSN-10-17 | PVAP pathogen eligibility and thresholds | 0 |
NHSN-10-18 | Secondary bloodstream infection with PVAP | 0 |
NHSN-10-19 | VAE numerator form and no-event report | 0 |
NHSN-10-20 | Ventilator and patient day denominators | 0 |
NHSN-10-21 | Report device days for SUR | 0 |
NHSN-10-22 | Calculate VAE rates and choose reporting measure | 0 |
NHSN-10-23 | Calculate device utilization by location | 0 |
NHSN-10-24 | Use VAE measures by application | 0 |
NHSN-10-25 | Use eligible antimicrobial list | 0 |
NHSN-10-26 | Restrict VAE surveillance to adult locations | 0 |
NHSN-10-27 | Collect daily VAE numerator data | 0 |
NHSN-10-28 | Define mechanical ventilation episodes | 0 |
NHSN-10-29 | Identify a new antimicrobial agent | 0 |
NHSN-10-30 | Count four qualifying antimicrobial days | 0 |
NHSN-10-31 | Do not report BSI for VAC or IVAC | 0 |
NHSN-10-32 | Apply PVAP pathogen and specimen rules | 0 |
NHSN-10-33 | Report secondary BSI for PVAP only when matched | 0 |
NHSN-10-34 | Use culture and non-culture PVAP results | 0 |
NHSN-10-35 | Accept lung tissue and pleural fluid findings | 0 |
NHSN-10-36 | Define purulent respiratory secretions | 0 |
NHSN-10-37 | Apply the VAE Window Period | 0 |
NHSN-10-38 | Apply VAE ventilation mode rules | 0 |
NHSN-10-39 | Report APRV status on NHSN forms | 0 |
NHSN-11-01 | Scope of pediatric ventilator event surveillance | 0 |
NHSN-11-02 | Locations eligible for PedVAE surveillance | 0 |
NHSN-11-03 | Patients covered and not covered | 0 |
NHSN-11-04 | Device counted as a ventilator | 0 |
NHSN-11-05 | Minimum ventilation days for an event | 0 |
NHSN-11-06 | Working out the daily minimum MAP | 0 |
NHSN-11-07 | Working out the daily minimum FiO2 | 0 |
NHSN-11-08 | Baseline period of stability | 0 |
NHSN-11-09 | Thresholds that define worsening oxygenation | 0 |
NHSN-11-10 | Setting the date of event | 0 |
NHSN-11-11 | The 14-day event period | 0 |
NHSN-11-12 | What makes a new ventilation episode | 0 |
NHSN-11-13 | Attributing events to a location | 0 |
NHSN-11-14 | Reporting rules and optional clinical detail | 0 |
NHSN-11-15 | Recording each PedVAE | 0 |
NHSN-11-16 | Counting ventilator days and patient days | 0 |
NHSN-11-17 | Validating electronic denominator counts | 0 |
NHSN-11-18 | Optional episodes of mechanical ventilation denominator | 0 |
NHSN-11-19 | Calculating PedVAE rates and device use | 0 |
NHSN-11-20 | Eligible antimicrobial agents for optional reporting | 0 |
NHSN-12-01 | Scope of the MDRO and CDI module | 0 |
NHSN-12-02 | Selecting a core method and location scope | 0 |
NHSN-12-03 | Core and supplemental reporting selections | 0 |
NHSN-12-04 | Basis and limits of LabID event reporting | 0 |
NHSN-12-05 | Specimen source limits and inpatient day counting | 0 |
NHSN-12-06 | Form requirements and denominator validation | 0 |
NHSN-12-07 | MDRO options and excluded surveillance results | 0 |
NHSN-12-08 | MDRO organism definitions and thresholds | 0 |
NHSN-12-09 | MDRO method choice and event rules | 0 |
NHSN-12-10 | MDRO numerator and denominator grouping | 0 |
NHSN-12-11 | Duplicate isolate and the 14-day rule | 0 |
NHSN-12-12 | Unique blood source definition | 0 |
NHSN-12-13 | Reporting events by unit location | 0 |
NHSN-12-14 | Numerator event form | 0 |
NHSN-12-15 | Denominator form and encounter definition | 0 |
NHSN-12-16 | Three-line facility-wide inpatient denominators | 0 |
NHSN-12-17 | C. difficile monitoring scope and settings | 0 |
NHSN-12-18 | C. difficile reporting options | 0 |
NHSN-12-19 | Positive C. difficile assay definition | 0 |
NHSN-12-20 | Duplicate positive test and 14-day rule | 0 |
NHSN-12-21 | C. difficile events and location mapping | 0 |
NHSN-12-22 | CDI LabID event numerator form | 0 |
NHSN-12-23 | Quarterly standard CDI test method | 0 |
NHSN-12-24 | Outpatient encounters and admission day one | 0 |
NHSN-12-25 | Community-onset CDI classification | 0 |
NHSN-12-26 | Community-onset healthcare facility-associated classification | 0 |
NHSN-12-27 | Healthcare facility-onset classification | 0 |
NHSN-12-28 | Incident and recurrent CDI events | 0 |
NHSN-12-29 | CDI rate table completeness | 0 |
NHSN-12-30 | CDI prevalence and incidence rates | 0 |
NHSN-12-31 | CDI standardized infection ratio reports | 0 |
NHSN-12-32 | MDRO infection surveillance duties | 0 |
NHSN-12-33 | CDI infection surveillance duties | 0 |
NHSN-12-34 | Hand hygiene and gown glove monitoring | 0 |
NHSN-12-35 | Active surveillance testing adherence | 0 |
NHSN-12-36 | Active surveillance testing outcomes | 0 |
NHSN-12-37 | Combined module reporting scenarios | 0 |
NHSN-12-38 | Facility-wide inpatient denominator counts | 0 |
NHSN-14-01 | AUR module scope and CDA only submission | 0 |
NHSN-14-02 | Purpose of the AUR module | 0 |
NHSN-14-03 | Objectives of the antimicrobial use option | 0 |
NHSN-14-04 | Primary and secondary use metrics | 0 |
NHSN-14-05 | Eligible facilities and location scope | 0 |
NHSN-14-06 | Map each location to one CDC Location | 0 |
NHSN-14-07 | Monthly plan and CDA file uploads | 0 |
NHSN-14-08 | Counting antimicrobial days from eMAR | 0 |
NHSN-14-09 | Stratify days by four routes | 0 |
NHSN-14-10 | A value for every agent and route | 0 |
NHSN-14-11 | Denominators matched to each analysis level | 0 |
NHSN-14-12 | Count patients present on any part of a day | 0 |
NHSN-14-13 | Admission counting for facility-wide inpatient | 0 |
NHSN-14-14 | Rate denominators and unit inclusion rules | 0 |
NHSN-14-15 | Reports available after submission | 0 |
NHSN-14-16 | How the SAAR is built and read | 0 |
NHSN-14-17 | Ranking locations with the AU-CAD | 0 |
NHSN-14-18 | Required fields in every CDA file | 0 |
NHSN-14-19 | Adult SAAR type by location | 0 |
NHSN-14-20 | Pediatric SAAR types by location | 0 |
NHSN-14-21 | Neonatal SAAR types by nursery level | 0 |
NHSN-14-22 | Antimicrobial groupings for SAAR and rate tables | 0 |